The "14th Five-Year Plan" for the development of the pharmaceutical industry clearly promotes the digital transformation and upgrading of the pharmaceutical and health industry, which means that the digital transformation and upgrading of enterprises in the pharmaceutical industry has become a general trend
.
However, most of China's pharmaceutical enterprises are mainly small and medium-sized, with large quantities and wide range, weak funds, and the challenges
of digital transformation.
Recently, the Ministry of Industry and Information Technology issued the Guidelines for the Digital Transformation of Small and Medium-sized Enterprises (hereinafter referred to as the "Guide"), which provides clear policy guidance
for clarifying the digital transformation path of small and medium-sized enterprises and improving the supply level of digital transformation products and services.
The Guidelines propose that digital transformation service providers should increase product, technology and model innovation to help SMEs achieve low-cost and efficient digital transformation, help SMEs connect with product and service ecological resources at different stages of transformation, deepen the collaboration between upstream and downstream enterprises in the industrial chain and supply chain, and help SMEs achieve "chain" transformation
.
The digital and intelligent transformation of the pharmaceutical industry is timely, and pharmaceutical equipment companies are helping (Image source: Pharmaceutical Network)
The industry believes that in the context of favorable policies + the survival challenges faced by traditional pharmaceutical companies, the digital and intelligent transformation of the pharmaceutical industry is timely, and the pharmaceutical equipment industry, as the upstream pharmaceutical equipment industry, also needs to pay attention to the development of pharmaceutical companies, help pharmaceutical companies digital transformation, and solve the difficulties and challenges
they face.
The digital transformation of the pharmaceutical industry is timely
In recent years, with the rapid development of new technologies such as digitalization, artificial intelligence, and 5G, it has brought great changes
to the traditional manufacturing industry.
In the pharmaceutical industry, affected by the policy environment such as the two-invoice system, the consistency evaluation of generic drugs, the normalization of centralized procurement, and medical insurance negotiation, the profit pressure of the pharmaceutical industry is obvious, and the competition between enterprises is becoming more and more fierce, and digital intelligence transformation has become a trend
that pharmaceutical companies have to embrace.
In October, Wuhan Medical Bank Digital Technology Co.
, Ltd.
, controlled by Hengrui Pharmaceutical, was established, and the business scope of the newly established company includes: pharmaceutical Internet information services; Internet information services; Medical device Internet information services; The second category of value-added telecommunications services, etc
.
In March this year, Jointown, a pharmaceutical circulation company, made it clear at the digital transformation promotion conference that digital transformation will continue to be promoted as a long-term work, and released a strategic blueprint to accelerate the process of building a digital Jointown to achieve the "Jointown Model" of digital transformation of pharmaceutical enterprises with "experience improvement, cost reduction and efficiency increase, accurate decision-making, and model innovation"
.
At present, both traditional pharmaceutical companies and pharmaceutical retail enterprises are actively deploying digital and intelligent transformation
.
The industry believes that driven by the wave of digital intelligence, pharmaceutical companies will move towards high efficiency and energy saving, and the entire industry will accelerate the reshuffle and usher in the reshaping
of the market pattern.
Pharmaceutical equipment companies to help
Standing at the key point of the digital and intelligent transformation of medicine, the upstream pharmaceutical equipment industry is also facing a situation
where opportunities and challenges coexist.
As the "mother machine" of pharmaceutical production, pharmaceutical equipment needs to be based on the new needs of pharmaceutical enterprises, transform towards more automation and intelligence, help pharmaceutical enterprises reduce costs and increase efficiency, and help the high-quality development of
the pharmaceutical industry.
For example, Dongfulong has been exploring the road of digital transformation to provide customers with digital products and services
.
The company's vision is to provide customers with products and services through internal digital construction, and then to build smart pharmaceutical factories for customers through external digital construction, so as to realize Dongfulong's corporate vision
of becoming a smart pharmaceutical factory deliverer.
Chutian Technology is also using new technologies to carry out digital and intelligent transformation
.
The company is committed to building a new model of intelligent manufacturing, building an intelligent factory of biomedical robots and high-end equipment, realizing efficient R&D and flexible manufacturing of customized medical equipment, and helping the pharmaceutical industry produce more efficiently and with high quality
.
In addition, in recent years, more and more pharmaceutical companies have chosen to "join hands" with pharmaceutical equipment companies, and with their advantages, jointly promote the digital and intelligent transformation of pharmaceutical enterprises, and explore more possibilities
for digital innovation in the pharmaceutical industry.
Recently, Canaan Zhi Pharmaceutical and Shenhua Pharmaceutical announced a "marriage", and the two parties reached a strategic cooperation to jointly build a digital production line of Brain Xinshu oral liquid to accelerate the digital and intelligent transformation
of Shenhua Pharmaceutical.
It is reported that the digital production line of Cenoxinshu oral liquid jointly built by the two parties will break the information islands in the workshop and the company through the SCADA and MES systems of Canaan Zhi Pharmaceutical on the basis of the existing automation of Shenhua Pharmaceutical, and the MES system will be connected to the SCADA system downward, integrating hardware equipment such as DCS and PLC to build a basic data layer; Upward docking with the company's ERP for data interaction
such as materials, production plans, and personnel information.
After the completion of the project, the information system will control the entire production process, and carry out data mining and decision support on the basis of large-scale data, and build a production business processing layer
.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
